Long-Term Safety With Axitinib in Previously Treated Patients With Metastatic Renal Cell Carcinoma

Title
Long-Term Safety With Axitinib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
Authors
Keywords
adverse events, tyrosine kinase inhibitor, vascular endothelial growth factor receptor
Journal
Clinical Genitourinary Cancer
Volume 13, Issue 6, Pages 540-547.e7
Publisher
Elsevier BV
Online
2015-07-21
DOI
10.1016/j.clgc.2015.07.001

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now